Avogadri et al.’s research suggested that amplifying mRNA cancer vaccine based on VEEV vector expressing TRP-2 induced Humoral immunity against TRP-2, played a role in immunotherapy of Melanoma, and cooperated with tumor specific CD8 T cell reaction (45). Here, CD8A is linked to neoplasm.